EPIGENETIC MECHANISM AND TARGETING DURING RESPONSE TO BRAFI/ANTI-EGFR THERAPY IN BRAF-MUTANT COLORECTAL CANCERS

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators